The US Department of Health and Human Services issued a statement on the 21st, confirming that 300 million doses of the new crown vaccine currently in the trial stage have been ordered from the British pharmaceutical company Astra-Zelicon, and promised to provide this company with 1.2 billion US dollars To accelerate vaccine development.


Under the big order

The U.S. government launched a plan called “Quick Action” in April to speed up the development of a new crown vaccine. Secretary of State for Health and Human Services Alex Aza said: “The contract with Astra-Zelikang is a major milestone for Zigzag to develop a safe, effective and widely available by 2021 Vaccine. “

According to the Ministry of Health and Human Services, the first batch of trials produced by Astra-Zelicon in the United States will be available as early as October this year Sex vaccine.

The University of Cambridge and Astra-Zelicon said they have received at least 400 million doses of vaccine reservations, which can ensure a capacity of 1 billion doses, and the first vaccines are expected It will be launched in September. Astra-Zelicon agreed to provide 100 million doses of vaccine to the UK, of which 30 million doses will be distributed as early as September. Several British cabinet ministers have previously promised that the British will get the vaccine first.


Guangsha.com

This vaccine is now called AZD1222 and was developed by the Cambridge University team. Astra-Zelicon obtained a production license.

It is temporarily unclear whether this vaccine is effective against the new coronavirus. The vaccine will start Phase I and Phase II clinical trials in April, injecting more than 1,000 volunteers between the ages of 18 and 55 at multiple trial centers in southern England to test the safety and effectiveness of the vaccine. The relevant data is expected to be released in the near future.

“Astra-Zelicon knows that this vaccine may not work,” the pharmaceutical company said, even if it will take risks, “the company still Will be committed to accelerating the promotion of clinical projects and expanding the scale of production. “

In addition to Astra-Zelicon, the US government also cooperates with Johnson & Johnson and Modena An agreement was reached with France Sanofi.

Sanofi said earlier,Vaccines produced in the United States may be given priority to Americans, a statement that angered the French government. (End) (Special Feature for Xinhua News Agency)

(Originally titled “U.S. Orders 300 Million Dose of New Crown Vaccine from British Pharmaceutical Companies”)